Found: 19
Select item for more details and to access through your institution.
Genetics, clinical features and outcomes of non-syndromic pituitary gigantism: experience of a single center from Sao Paulo, Brazil.
- Published in:
- Pituitary, 2021, v. 24, n. 2, p. 252, doi. 10.1007/s11102-020-01105-4
- By:
- Publication type:
- Article
Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas.
- Published in:
- Pituitary, 2018, v. 21, n. 4, p. 355, doi. 10.1007/s11102-018-0881-7
- By:
- Publication type:
- Article
SOCS2 polymorphisms are not associated with clinical and biochemical phenotypes in acromegalic patients.
- Published in:
- Pituitary, 2017, v. 20, n. 3, p. 319, doi. 10.1007/s11102-016-0779-1
- By:
- Publication type:
- Article
Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.
- Published in:
- Pituitary, 2016, v. 19, n. 4, p. 448, doi. 10.1007/s11102-016-0725-2
- By:
- Publication type:
- Article
Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly.
- Published in:
- Pituitary, 2015, v. 18, n. 5, p. 666, doi. 10.1007/s11102-014-0629-y
- By:
- Publication type:
- Article
The impact of sleep apnea treatment on carbohydrate metabolism in patients with acromegaly.
- Published in:
- Pituitary, 2013, v. 16, n. 3, p. 341, doi. 10.1007/s11102-012-0430-8
- By:
- Publication type:
- Article
Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment.
- Published in:
- Pituitary, 2009, v. 12, n. 4, p. 297, doi. 10.1007/s11102-009-0175-1
- By:
- Publication type:
- Article
Treatment of acromegaly: is there still a place for radiotherapy?
- Published in:
- Pituitary, 2007, v. 10, n. 1, p. 53, doi. 10.1007/s11102-007-0002-5
- By:
- Publication type:
- Article
Genetic investigation of patients with tall stature.
- Published in:
- European Journal of Endocrinology, 2020, v. 182, n. 2, p. 139, doi. 10.1530/EJE-19-0785
- By:
- Publication type:
- Article
Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors.
- Published in:
- European Journal of Endocrinology, 2015, v. 172, n. 6, p. 707, doi. 10.1530/EJE-14-1117
- By:
- Publication type:
- Article
Survivin: A Potential Marker of Resistance to Somatostatin Receptor Ligands.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 4, p. 876, doi. 10.1210/clinem/dgac610
- By:
- Publication type:
- Article
Impaired Bone Microarchitecture in Premenopausal Women With Acromegaly: The Possible Role of Wnt Signaling.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Machine Learning-based Prediction Model for Treatment of Acromegaly With First-generation Somatostatin Receptor Ligands.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Estrogens and selective estrogen receptor modulators in acromegaly.
- Published in:
- Endocrine (1355008X), 2016, v. 54, n. 2, p. 306, doi. 10.1007/s12020-016-1118-z
- By:
- Publication type:
- Article
Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
- Published in:
- Clinical Endocrinology, 2007, v. 67, n. 2, p. 310, doi. 10.1111/j.1365-2265.2007.02885.x
- By:
- Publication type:
- Article
Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
- Published in:
- Clinical Endocrinology, 2005, v. 63, n. 2, p. 168, doi. 10.1111/j.1365-2265.2005.02317.x
- By:
- Publication type:
- Article
The interplay between prolactin and cardiovascular disease.
- Published in:
- Frontiers in Endocrinology, 2023, v. 13, p. 1, doi. 10.3389/fendo.2022.1018090
- By:
- Publication type:
- Article
Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable Event.
- Published in:
- Neuroendocrinology, 2017, v. 104, n. 3, p. 273, doi. 10.1159/000446542
- By:
- Publication type:
- Article
Optimizing Medical Therapy of Acromegaly: Beneficial Effects of Cabergoline in Patients Uncontrolled with Long-Acting Release Octreotide.
- Published in:
- Neuroendocrinology, 2009, v. 90, n. 1, p. 82, doi. 10.1159/000218323
- By:
- Publication type:
- Article